Category Archive for: ‘Pradaxa’

Pradaxa is ‘promising drug with a flaw’

A New York Times article chronicles the history of the anticoagulant drug Pradaxa, issued by Boehringer Ingelheim as an alternative to warfarin (brand name: Coumadin). According to the article, “A Promising Drug With a Flaw,” “Pradaxa is an example, some critics say, of what can happen when a drug that performs well in tightly controlled trials is released into the …

Read More